In order to comprehend the significance of DACH1 expression in liver benign as well as malignant lesions, we analyzed DACH1 protein levels in a TMA containing 120 informative patients with various hepatic lesions, which mainly included cirrhosis, steatosis, chronic hepatitis, hemangioma and cancer. This evidence concerns the gene DACH1 and Cirrhosis.